drugset / Trial / NCT06515184
Coenzyme Q10 for Gulf War Illness: A Replication Study
Phase 3
Recruiting
192 enrolled
University of California, San Diego
United States Department of Defense · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.
Timeline
- Start
- 2024-09-13
- Primary completion
- 2027-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Coenzyme Q10 | Other / unclassified | 100 mg | Oral |